5 Key Takeaways
-
1
CAR T Vision is a multidisciplinary coalition formed to address access barriers and double the proportion of eligible patients receiving CAR T therapy by 2030.
-
2
Its Vision to Action Blueprint offers stakeholders a framework for identifying barriers and actions related to awareness and education, capacity, and sustainable funding and reimbursement.
-
3
The coalition says expanding CAR T indications could increase the number of eligible patients beyond the capacity of the current delivery system.
-
4
Community oncology practices may deliver CAR T closer to patients’ homes, with acute care provider collaboration remaining important when adverse events cannot be managed locally.
-
5
The coalition calls for community sites in clinical trials, clearer patient education, streamlined product onboarding, sustainable financial models, and less administrative burden.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.